Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The René Huguenin Cancer Center is a specialized oncology facility located in Saint-Cloud, France, that merged with the Institut Curie in 2010. It serves as a major clinical site for the diagnosis and treatment of solid tumors, with a particular global reputation for its expertise in breast cancer. The center integrates advanced medical imaging, radiotherapy, and surgical oncology with a robust clinical research infrastructure. As part of the Institut Curie, it participates in numerous international clinical trials and translational research projects aimed at developing personalized cancer therapies. The facility remains a key component of the French "Centres de Lutte Contre le Cancer" network, providing comprehensive care to thousands of patients annually.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on René Huguenin Cancer Center.